Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Fortress Biotech Inc has a consensus price target of $10.14 based on the ratings of 8 analysts. The high is $24 issued by HC Wainwright & Co. on July 19, 2024. The low is $5 issued by Alliance Global Partners on March 19, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Roth MKM, and Alliance Global Partners on July 19, 2024, May 16, 2024, and March 19, 2024, respectively. With an average price target of $13 between HC Wainwright & Co., Roth MKM, and Alliance Global Partners, there's an implied 802.78% upside for Fortress Biotech Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Fortress Biotech (NASDAQ:FBIO) was reported by HC Wainwright & Co. on July 19, 2024. The analyst firm set a price target for $24.00 expecting FBIO to rise to within 12 months (a possible 1566.67% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Fortress Biotech (NASDAQ:FBIO) was provided by HC Wainwright & Co., and Fortress Biotech reiterated their buy rating.
There is no last upgrade for Fortress Biotech
There is no last downgrade for Fortress Biotech.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fortress Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fortress Biotech was filed on July 19, 2024 so you should expect the next rating to be made available sometime around July 19, 2025.
While ratings are subjective and will change, the latest Fortress Biotech (FBIO) rating was a reiterated with a price target of $24.00 to $24.00. The current price Fortress Biotech (FBIO) is trading at is $1.44, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.